Skip to main content
Log in

Fosfomycin has similar costs to other antibiotics for uUTIs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Canadian dollars

Reference

  • Perrault L, et al. Cost-Effectiveness Analysis of Fosfomycin for Treatment of Uncomplicated Urinary Tract Infections in Ontario. Canadian Journal of Infectious Diseases and Medical Microbiology 2017: 6362804, Jan 2017. Available from: URL: http://doi.org/10.1155/2017/6362804

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fosfomycin has similar costs to other antibiotics for uUTIs. PharmacoEcon Outcomes News 788, 17 (2017). https://doi.org/10.1007/s40274-017-4385-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4385-x

Navigation